????????? ????? ??????? ???????? ???????????????????? ????????? ????Duvelisib was the second PI3K inhibitor permitted with the FDA, also dependant on a phase III randomized trial.one hundred thirty The efficacy and basic safety profile of your drug appear similar with those of idelalisib, Otherwise slightly beneficial. Regarding choice BTK inhibito